We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

1 hedge funds and large institutions have $697 invested in Genetic Technologies Ltd. in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

76% less capital invested

Capital invested by funds: $2.86K → $697 (-$2.16K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$697 – – –

GENE Hedge Fund Activity: Q1 2025 in Review

1 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2025, worth a combined $697 — down 76% from $2.86K a quarter earlier.

Fund positioning in GENE was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Genetic Technologies Ltd. (GENE) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $697 of Genetic Technologies Ltd. stock for Q1 2025, down 76% quarter-over-quarter.
  • 0 funds opened new Genetic Technologies Ltd. positions in Q1 2025 and 0 closed out.

Based on aggregated 13F filings for Q1 2025.